MarkIt to Market® - March 2021: GW Pharma Seeks Dismissal of Patent Suit Filed in Texas by Canopy Growth
By EsqSocial Corporation 09/04/21
We have been keeping a close eye on the patent suit filed by Canopy Growth against GW Pharma in the Western District of Texas’s Waco Division, a venue that has attained recent fame for its speed to trial in patent litigation. In its complaint, Canopy has alleged infringement of a patent directed to cannabinoid extraction technology, accusing activities related to GW Pharma’s FDA-approved epilepsy drug, EPIDIOLEX®. In a more recent development, GW Pharma has moved to dismiss Canopy’s suit,...
By: Sterne, Kessler, Goldstein & Fox P.L.L.C.